Optimizing Synthetic Correlated Diffusion Imaging for Breast Cancer Tumour Delineation (2405.08049v1)
Abstract: Breast cancer is a significant cause of death from cancer in women globally, highlighting the need for improved diagnostic imaging to enhance patient outcomes. Accurate tumour identification is essential for diagnosis, treatment, and monitoring, emphasizing the importance of advanced imaging technologies that provide detailed views of tumour characteristics and disease. Synthetic correlated diffusion imaging (CDI$s$) is a recent method that has shown promise for prostate cancer delineation compared to current MRI images. In this paper, we explore tuning the coefficients in the computation of CDI$s$ for breast cancer tumour delineation by maximizing the area under the receiver operating characteristic curve (AUC) using a Nelder-Mead simplex optimization strategy. We show that the best AUC is achieved by the CDI$s$ - Optimized modality, outperforming the best gold-standard modality by 0.0044. Notably, the optimized CDI$s$ modality also achieves AUC values over 0.02 higher than the Unoptimized CDI$s$ value, demonstrating the importance of optimizing the CDI$s$ exponents for the specific cancer application.
- Chemotherapeutic nanomaterials in tumor boundary delineation: Prospects for effective tumor treatment. Acta Pharmaceutica Sinica B, 12(6):2640–2657, 2022.
- The cancer imaging archive (tcia): Maintaining and operating a public information repository. Journal of Digital Imaging, 26(6):1045–1057, 2013.
- Delineation and detection of breast cancer using novel label-free fluorescence. BMC Medical Imaging, 23(1):132, 2023.
- A simplex method for function minimization. The computer journal, 7(4):308–313, 1965.
- Test–retest repeatability and reproducibility of adc measures by breast dwi: Results from the acrin 6698 trial. Journal of Magnetic Resonance Imaging, 49(6):1617–1628, 2018.
- Acrin 6698/i-spy2 breast dwi [data set]. The Cancer Imaging Archive, 2021.
- Diffusion-weighted mri findings predict pathologic response in neoadjuvant treatment of breast cancer: The acrin 6698 multicenter trial. Radiology, 289(3):618–627, 2018.
- Canadian Cancer Society. Breast cancer statistics. https://cancer.ca/en/cancer-information/cancer-types/breast/statistics, 2024. Accessed: 2024-03-06.
- Cancer-net bca: Breast cancer pathologic complete response prediction using volumetric deep radiomic features from synthetic correlated diffusion imaging. arXiv preprint arXiv:2211.05308, 2022.
- A multi-institutional open-source benchmark dataset for breast cancer clinical decision support using synthetic correlated diffusion imaging data. arXiv preprint arXiv:2304.05623, 2023.
- Synthetic correlated diffusion imaging hyperintensity delineates clinically significant prostate cancer. Scientific Reports, 12(1):3376, 2022.